Hybrid. Who knew a year ago this unremarkable word would have such a large part to play in pharma’s future lexicon and strategy building? Executives across the industry are working tirelessly to devise and execute a model in which pharma sales reps and other customer facing roles balance face-to-face (F2F), remote, and digital engagement.
Many questions remain unanswered; what is the right balance of F2F and remote engagement?
How do you create and maintain new relationships in the remote environment? How can we demonstrate what does – and doesn’t – and rapidly adapt and improve? Find out answers in this webinar Hybrid: Go-To-Market Models, Roles, and Capabilities for HCP Engagement.
Sign up now to join the session on Wednesday 5 May 2021 at 9 am EST/ 2pm BST/ 3pm CET.
Gain insight from this exclusive line-up of senior level executives:
- George Katzourakis, SVP, Head of Europe, GSK
- Cyril Schiever, SVP, President Mid-Europe Region, MSD
- Janneke van der Kamp, Head Region Europe, Novartis
- Brent Hooper, Partner, McKinsey
- Christina Hoffmann, Associate Partner, McKinsey
Join the discussion to learn how to combine F2F, remote, and digital engagement strategies.
Don’t miss what is sure to be a popular session – sign up now.
Thanks to Matt Atkinson, Global Project Director, Reuters Events Pharma. If you have any questions, don’t hesitate to contact him at matt.atkinson@thomsonreuters.com
Kind regards,
Lucy Muñiz
Editor/Founder
The Pharmaceutical Marketing Group
